Pediatric Services
Patient Resources
For Professionals
Supporting Children's
Job Opportunities

Connect with Children's
Facebook Twitter YouTube RSS

  Print this page Email this page
     
Bookmark and Share
     

 Pediatric Services

Aflac Cancer Center and Blood Disorders Service

Kuang-Yueh Chiang, M.D., Ph.D.

Kuang-Yueh Chiang, M.D., Ph.D.Pediatric Hematology/Oncology
Blood and Marrow Transplant Program
Aflac Cancer Center and Blood Disorders Service
Children’s Healthcare of Atlanta at Egleston
2015 Uppergate Drive NE
Fourth Floor
Atlanta, GA  30322
404-785-1200

Associate Professor of Pediatrics
Emory University School of Medicine

Education/Training

Medical Degree: Kaohsiung Medical College, Taiwan, Republic of China, 1975-82
Doctoral Degree: Department of Physiology, University of Minnesota, 1985-89
Internship: Department of Pediatrics, University of Minnesota, 1989-90
Residency: Department of Pediatrics, University of Minnesota, 1990-92
Fellowship: Department of Pediatrics, Division of Pediatric Hematology/Oncology/BMT, University of Minnesota, 1992-95

Honors/Awards

  • Travel Award, International Society of Experimental Hematology, 1998
  • Hsin-Kuang Life Insurance Scholarship, 1976

Professional Societies

  • International Society of Experimental Hematology
  • American Society for Blood and Marrow Transplantation
  • American Academy of Medical Acupuncture

Areas of Interest/Research

  • Stem cell transplantation
  • Immune tolerance

Publications/Presentations

Selected journal articles authored/co-authored by this physician are available at the National Library of Medicine

  1. Chiang KY, van Rhee F, Godder K, Bridges K, Adams S, Mehta J, Henslee-Downey PJ. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia. Bone Marrow Transplant. 2001;27:507-510.
  2. Chiang KY, Hazlett LJ, Godder KT, Abhyankar SH, Christiansen NP, van Rhee F, Lee CG, Bridges K, Parrish RS, Henslee-Downey PJ. Low Incidence of Epstein-Barr virus-associated B-cell lymphoproliferative disorder following partially mismatched related donor T-cell depleted bone marrow transplantation Bone Marrow Transplant. 2001;28:1117-1124.
  3. Chiang KY, Abhyankar S, Bridges K, Godder K, Henslee-Downey PJ. Recombinant human tumor necrosis factor receptor fusion protein (Enbrel) as complementary treatment for chronic graft-versus-host disease. Transplantation 2002;73;665-667.
  4. Chiang KY, Lamb L, Clark J, Worthington-White DA, Rich I, Henslee-Downey PJ. Assessment of Granulocyte Colony-Stimulating Factor-stimulated bone marrow hematopoietic stem cells in normal donors Cytotherapy 2002;4:55-63.
  5. Chiang KY and HM Lazarus. Should We Be Performing More Combined Hematopoietic Stem Cell Plus Solid Organ Transplants? Bone Marrow Transplant 2003;31:633-642.
  6. Mehta J, SinghalS, Gee AP, Chiang KY, Godder K, van Rhee F, DeRienzo S, O’Neal W, Lamb L, Henslee-Downey PJ. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia:single-center experience of 201 patients. Bone Marrow Transplant 2004;33:389-396.
  7. Chiang KY, Haight A, Horan J, Olson E, Gartner A, Hartman D, Youssef S, Worthington-White D. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor primed bone marrow and steady-state bone marrow. Pediatr Transplant 2007;11:279-285.
  8. Gu L, Chiang KY, Zhu N, Findley HW and Zhou M. Contribution of STAT3 to the activation of surviving by GM-CSF in CD34+ cell lines. Exp Hematol 2007;35:957-966.
  9. Ide LM, Gangadharan B, Chiang KY, Doering CB and Spencer HT. Hematopoietic stem cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimen. Blood 2007;110:2855-2863.
  10. Esiashvile N, Chiang KY, Hasselle MD, Bryant C, Riffenburgh RH and Paulino AC. Renal tosicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 2009;90:242-246.
  11. McPherson ME, Hutcherson D, Olson E, Haight AE, Horan J and Chiang KY. Safety and eefficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease. Bone Marrow Transplant 2010 March 22 (Epub ahead of print).
  12. Qayed M, Thompson A, Applegate K, Haight A, Rogatko A, Chiang KY and Horan J. Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation? Pediatr Blood Cancer 2010;55:199-201.